There are people on this site, talking down MEB, who are most likely stooges set up by the 249D protagonists. I'm confident that the 249D bid will be defeated comprehensively. The company has a comfortable cash bank and the board and management are currently stable. A search has progressed for a suitable CEO candidate and i'm looking forward to seeing that new CEO in Australia once settled in. Investors should not be taking advice from the peanut gallery in this forum who are talking about things that they have no idea about.
Brian Mower is an experienced MedTech executive and the board is solidly behind him and the business. As far as Medibio is concerned its full steam ahead and business is the focus. It is only a few on here who are creating a frenzy in their own minds.
R (DYOR)
There are people on this site, talking down MEB, who are most...
Add TRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.003(10.3%) |
Mkt cap ! $10.83M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.5¢ | 3.1¢ | $255.1K | 7.729M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1548058 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 369959 | 3 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.3¢ |
Change
0.003 ( 6.11 %) |
||||
| Open | High | Low | Volume | ||
| 3.3¢ | 3.5¢ | 3.2¢ | 1613468 | ||
| Last updated 13.48pm 03/05/2024 ? | |||||
| TRI (ASX) Chart |